Riskpilot← Back to searchSign inGet full accessBarnik Invest AB
ABActiveOrg 5590007182Rösjövägen 25Activities of holding companies · NACE 6421Est. 20150 employees
Revenue 2024
SEK 760K
+153% vs 2023
EBITDA margin
18.5%
-34% vs 2023
Equity ratio
7.4%
Financial strength
Net profit 2024
SEK 20K
+53% vs 2023
| Revenue | SEK 760K | +153% |
| EBITDA | SEK 140K | -34% |
| Net profit | SEK 20K | +53% |
| Total assets | SEK 11,1M | +26% |
| Equity | SEK 820K | +29% |
| Employees | 0 | — |
Legal name
Barnik Invest AB
Org number
5590007182
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
16 januari 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Företaget bedriver konsultverksamhet och bistår med management consulting gentemot Life Science sektor och inom den egna koncernen samt äger och förvaltar fastigheter och tillgångar.
Address
Rösjövägen 25
Email
info@medicorent.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 300 | 300 | 300 | 300 | 760 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 193 | 203 | 217 | 212 | 140 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 193 | 203 | 217 | 212 | 140 |
| Net financials | −84 | −128 | −52 | −96 | −116 |
| Profit before tax | 110 | 112 | −0 | 16 | 25 |
| Tax | −23 | −23 | — | −3 | −5 |
| Net profit | 87 | 89 | −0 | 13 | 20 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 568 | 4 470 | 5 420 | 8 797 | 11 105 |
| Equity | 146 | 235 | 235 | 635 | 820 |
| Long-term debt | 3 205 | 3 989 | 4 016 | 4 400 | 7 284 |
| Short-term debt | 218 | 246 | 1 169 | 3 763 | 3 001 |
| Total debt | 3 423 | 4 235 | 5 185 | 8 162 | 10 285 |
EBITDA margin
18.5%
This company
15.8%
Market median
+17% vs market
20202024
Equity ratio
7.4%
This company
38.2%
Market median
-81% vs market
20202024
Return on equity
2.4%
This company
18.4%
Market median
-87% vs market
20202024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
12.54×
This company
0.62×
Market median
-1923% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BS Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Barnik Invest AB 
Medicorent Int. ABBoard members of Barnik Invest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Sonny Malmquist | Audit | 0 companies |
| Mozhgan Hessam Amiri | Deputy Board Member | 0 companies |
| Hamid Baradaran Bakhshi | Chairman | 0 companies |
| Sara Nikman | Board of Directors | 0 companies |